Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients

Marcello Disertori; Michela Masè; Marta Rigoni; Giandomenico Nollo; Eloisa Arbustini; Flavia Ravelli

doi:10.3389/fphys.2017.00873

Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients

Front Physiol. 2017 Oct 31:8:873. doi: 10.3389/fphys.2017.00873. eCollection 2017.

Authors

Marcello Disertori^{1

2}, Michela Masè³, Marta Rigoni¹, Giandomenico Nollo¹, Eloisa Arbustini⁴, Flavia Ravelli³

Affiliations

¹ Healthcare Research and Innovation Program, Autonomous Province of Trento and Bruno Kessler Foundation, Trento, Italy.
² Department of Cardiology, Santa Chiara Hospital, Trento, Italy.
³ Laboratory of Biophysics and Biosignals, Department of Physics, University of Trento, Trento, Italy.
⁴ Centre for Inherited Cardiovascular Diseases, University Hospital Policlinico San Matteo, Pavia, Italy.

No abstract available

Keywords: dilated cardiomyopathy; genetics; heart failure; implantable cardioverter-defibrillator; late gadolinium enhancement; sudden cardiac death; ventricular arrhythmias.